Skip to main content
Icelandic Medicines Agency Frontpage
Icelandic Medicines Agency Frontpage

Icelandic Medicines Agency

Advertising of medicinal products

The Icelandic Medicines Agency (IMA) has published a guide on the advertising of medicinal products. Administrative decisions relating to the advertising of medicinal products can be found here.

The main rule of the Medicinal Products Act on the advertising of medicinal products is set out in Article 54 of the Medicinal Products Act, No. 100/2020, and provides that the advertising of medicinal products is permitted in Iceland subject to the restrictions referred to in Chapter XIII of the Act. In addition, the Regulation on the Advertising of Medicinal Products, No. 790/2021, is in force.

Administrative decisions

To increase transparency in its activities, IMA began publishing administrative decisions relating to the advertising of medicinal products on its website as of 1 January 2020, e.g. prohibitions of advertising of medicinal products or reprimands issued by IMA.

Please note that publication will only cover decisions taken from the first date of publication onwards.

Subject

Date

Document

Broksil advertisement in a brochure

June 2023

Letter

Túfen advertisement

June 2023

Letter

Parapró - advertisement in online media

December 2022

Letter

Voltaren gel - television advertisement

June 2022

Letter

Dolorin Junior advertisement in a magazine

March 2022

Letter

Paradorm advertisement on social media

August 2021

Letter

Zensitin advertisement in a podcast

March 2021

Letter

Ivermectin advertisements on Facebook

January 2021

Letter

Botox advertisements on Facebook

March 2020

Letter

Dolorin banner advertisement on a website

March 2020

Letter

Ibuprofen Bril advertisement at a football ground

March 2020

Letter